TPI 287
information and resources from the National Cancer Institute
NCI Thesaurus | TPI 287
A synthetic, third generation taxane with potential antineoplastic activity. TPI 287 binds to tubulin and stabilizes microtubules, resulting in inhibition of microtubule assembly/disassembly dynamics, cell cycle arrest at the G2/M phase, and apoptosis. NCI Thesaurus | TPI 287
A synthetic, third generation taxane with potential antineoplastic activity. TPI 287 binds to tubulin and stabilizes microtubules, resulting in inhibition of microtubule assembly/disassembly dynamics, cell cycle arrest at the G2/M phase, and apoptosis.
|
|
|
|
news articles
Tapestry Presents Data Characterizing Its Novel Third Generation ... Nov 16, 2005
PR Newswire (press release), 16 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. (Nasdaq: TPPH) will today present data on its lead oncology drug candidate TPI 287 at the AACR/NCI ...
(PRN) - New and Improved Martek DHA(TM) Now Available ... [+] Nov 16, 2005
Bolsamania.com, ...[+]. (PRN) - Tapestry Presents Data Characterizing Its Novel Third Generation Taxane, TPI 287, at AACR/NCI/EORTC Cancer Meeting ... [+. ...
|
|
